QC
PAHC icon

Quadrature Capital’s Phibro Animal Health PAHC Stock Holding History

Quadrature Capital’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
+3,810
New +$181K ﹤0.01% 1103

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Quadrature Capital's PAHC Position: Q1 2026 in Review

Quadrature Capital opened a new position in Phibro Animal Health (PAHC) in Q1 2026: 3,810 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #1103 among its holdings.

257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Quadrature Capital held 3,810 shares of Phibro Animal Health worth $211K as of Q1 2026.
  • Phibro Animal Health was a new Quadrature Capital position in Q1 2026.
  • Phibro Animal Health made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1103 holding.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.